Literature DB >> 33506880

MiR-140-5p targets BCL2L1 to promote cardiomyocyte apoptosis.

M-Y Sun1, L-P Li.   

Abstract

The article "MiR-140-5p targets BCL2L1 to promote cardiomyocyte apoptosis, by M.-Y. Sun, L.-P. Li, published in Eur Rev Med Pharmacol Sci 2020; 24 (11): 6311-6322-DOI: 10.26355/eurrev_202006_21529-PMID: 32572928" has been withdrawn from the authors. They stated that "they are still working on this study" and that "they found some current experimental results which are inconsistent with the previous ones. Moreover, they added that "these inconsistent results may be caused by the contamination of the previous experimental cell lines". The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/21529.

Entities:  

Year:  2021        PMID: 33506880     DOI: 10.26355/eurrev_202101_24298

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  1 in total

1.  CircZNF644 aggravates lipopolysaccharide-induced HK-2 cell impairment via the miR-140-5p/MLKL axis.

Authors:  Jing Xing; Songtao Fan; Hongyang Liu; Su Zhang; Nan Li
Journal:  J Bioenerg Biomembr       Date:  2022-08-17       Impact factor: 3.853

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.